P0J.F APTAMER GROUP LTD LS-001

Healthcare Biotechnology Frankfurt Exchange
0.0010 EUR
Close of Nov 12, 2026
0.0005 0.0250
Market cap
EUR 3.47M
P/E
-
P/B
0.25x
ROE
-175.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Jun 2025.

Is P0J.F undervalued?

Graham number

The Graham number of APTAMER GROUP LTD LS-001 cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

APTAMER GROUP LTD LS-001 fundamental analysis

No fundamental analysis for APTAMER GROUP LTD LS-001 yet.

APTAMER GROUP LTD LS-001 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About APTAMER GROUP LTD LS-001

Aptamer Group PLC, together with its subsidiaries, provides synthetic binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally. The company offers Optimer, a platform that enables the discovery and development of optimized DNA and RNA aptamers, which can bind to target molecules. Its platform is used in research reagent and analytical, bioprocessing, diagnostic, cosmetic and consumer health, and therape…

Full company profile